Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment
- PMID: 6202988
- DOI: 10.1016/0047-6374(84)90140-4
Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment
Abstract
The number of nerve cells in the nucleus basalis of Meynert in normally aged persons is reduced by 30% by 90 years of age and cytoplasmic RNA content and nucleolar volume by about 20%. In Alzheimer's disease the changes are greatly exacerbated, with the cell number being depleted by a further 60% and cytoplasmic RNA content and nucleolar volume by an extra 35%. Moreover, younger patients with Alzheimer's disease show a much greater difference from controls of the same age than do older patients; indeed, by 90 years of age the levels of these changes are similar in Alzheimer's disease and in old age alone. Lipofuscin content is increased to a similar extent with age in both Alzheimer's disease and control patients and was associated with loss of cytoplasmic RNA content and nucleolar volume in both groups. It is suggested that mechanisms which result in the accumulation of this pigment during life also lower the capability of cells of the nucleus basalis of Meynert to withstand disease pathogens, leading to a certain degree of change in old age alone and one which in other persons may be compounded by secondary factors giving the extreme degeneration of Alzheimer's disease.
Similar articles
-
A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.J Neurol Neurosurg Psychiatry. 1984 Feb;47(2):201-3. doi: 10.1136/jnnp.47.2.201. J Neurol Neurosurg Psychiatry. 1984. PMID: 6707659 Free PMC article.
-
The nucleus basalis of Meynert in multi-infarct (vascular) dementia.Acta Neuropathol. 1986;71(3-4):332-7. doi: 10.1007/BF00688058. Acta Neuropathol. 1986. PMID: 3799146
-
Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.Neurosci Lett. 1984 Jul 13;48(1):81-5. doi: 10.1016/0304-3940(84)90292-1. Neurosci Lett. 1984. PMID: 6472737
-
Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.Neurobiol Aging. 1990 Jan-Feb;11(1):3-13. doi: 10.1016/0197-4580(90)90056-6. Neurobiol Aging. 1990. PMID: 2183081 Review.
-
Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease.J Neural Transm Suppl. 1987;24:139-46. J Neural Transm Suppl. 1987. PMID: 3119773 Review.
Cited by
-
The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.Hum Brain Mapp. 2011 Sep;32(9):1349-62. doi: 10.1002/hbm.21111. Epub 2010 Jul 29. Hum Brain Mapp. 2011. PMID: 20672311 Free PMC article.
-
Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.Biol Psychiatry. 2012 May 1;71(9):805-13. doi: 10.1016/j.biopsych.2011.06.019. Epub 2011 Aug 4. Biol Psychiatry. 2012. PMID: 21816388 Free PMC article.
-
Bacterial melanin crosses the blood-brain barrier in rat experimental model.Fluids Barriers CNS. 2014 Aug 25;11:20. doi: 10.1186/2045-8118-11-20. eCollection 2014. Fluids Barriers CNS. 2014. PMID: 25184034 Free PMC article.
-
Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age.J Neurol Neurosurg Psychiatry. 1987 Mar;50(3):341-4. doi: 10.1136/jnnp.50.3.341. J Neurol Neurosurg Psychiatry. 1987. PMID: 2951499 Free PMC article.
-
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.J Neurochem. 2021 Sep;158(6):1394-1411. doi: 10.1111/jnc.15471. Epub 2021 Aug 6. J Neurochem. 2021. PMID: 34272732 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical